Equities research analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a report released on Sunday. The brokerage set a “hold” rating on the stock.
Milestone Scientific Stock Performance
Shares of MLSS opened at $1.01 on Friday. The firm’s fifty day simple moving average is $1.11 and its two-hundred day simple moving average is $0.96. Milestone Scientific has a 12 month low of $0.54 and a 12 month high of $1.39. The stock has a market capitalization of $78.67 million, a P/E ratio of -14.43 and a beta of 1.41.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. Y Intercept Hong Kong Ltd bought a new stake in Milestone Scientific in the third quarter valued at $48,000. World Investment Advisors LLC bought a new stake in Milestone Scientific during the third quarter worth $91,000. Renaissance Technologies LLC boosted its holdings in Milestone Scientific by 72.8% during the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after acquiring an additional 53,198 shares during the last quarter. Carnegie Investment Counsel boosted its holdings in Milestone Scientific by 18.9% during the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after acquiring an additional 27,412 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after acquiring an additional 31,572 shares in the last quarter. Institutional investors and hedge funds own 5.79% of the company’s stock.
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Stories
- Five stocks we like better than Milestone Scientific
- Compound Interest and Why It Matters When Investing
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- How to find penny stocks to invest and tradeĀ
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- How to Short a Stock in 5 Easy StepsĀ
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.